daunoxome

DRUG2 trials

Sponsors

Gruppo Italiano Malattie EMatologiche dell'Adulto, University Hospital Schleswig-Holstein

Conditions

AMLElderlyLeukemia

Phase 3

DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML

CompletedNCT00589082

Gruppo Italiano Malattie EMatologiche dell'AdultoAML, Elderly

Start: 2001-10-31End: 2005-11-30Updated: 2008-01-09

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia

CompletedNCT01117441

University Hospital Schleswig-HolsteinLeukemia

Start: 2010-06-30End: 2021-12-31Updated: 2022-05-24

Related Papers

Unfavorable outcomes in pediatric PAX5r B-cell precursor acute lymphoblastic leukemia: FLT3 targeting as a potential novel treatment strategy

Blood2025-11-03

Multi-omic analysis of early minimal residual disease identifies functional and transcriptomic signatures of treatment resistance in pediatric B-cell acute lymphoblastic leukemia

Blood2025-11-03

<i>Crebbp</i> Mutations Are Associated with Slow Minimal Residual Response to Upfront Induction Chemotherapy in Pediatric High-Hyperdiploid B-Cell Precursor Acute Lymphoblastic Leukemia Treated in the AIEOP-BFM ALL 2009 Protocol

Blood2023-11-02

Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia

Haematologica2023-04-063 citations

Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data.

2021-02-1710 citations

High <i>EVI1</i> Expression due to <i>NRIP1/EVI1</i> Fusion in Therapy‐related Acute Myeloid Leukemia: Description of the First Pediatric Case

HemaSphere2020-09-173 citations

Incidence of Hypersensitivity Reactions (HSR) Reactions (HSR) to Peg-Asparaginase (PEG-ASP) in 6136 Patients Treated in the AIEOP-BFM ALL 2009 Study Protocol

Blood2019-11-135 citations

Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols

Haematologica2019-10-1056 citations

Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimen

Haematologica2019-08-0141 citations